Kdb Venture

KDB Venture is the venture capital arm of Korea Development Bank (KDB), one of Korea's largest policy banks with over $100B in assets. The firm invests in Korean technology companies with particular emphasis on deep tech and national strategic technologies.

As a policy bank-affiliated VC, KDB Venture brings unique positioning supporting Korean technology development goals. Investment thesis aligns with Korean government priorities for technological independence and strategic industry development.

The firm's investment focus spans semiconductor, biotechnology, advanced materials, and industrial technology. These sectors represent Korean national priorities where domestic capability development has strategic importance.

With typical investment ranges of $100K to $20M, KDB Venture provides meaningful capital support for Korean seed and early-stage companies. The firm's patient capital approach supports extended development timelines typical of deep tech.

Korean founders value KDB Venture for the institutional credibility and network access the KDB affiliation provides. The relationship opens doors to Korean industrial conglomerates and government research institutions.

For Korean technology companies developing strategic capabilities, KDB Venture offers capital with strategic purpose—investment aligned with national development objectives while creating commercial opportunity.

KDB Venture maintains a clear thesis centered on Korean technology independence and strategic industry development. The firm invests in companies advancing domestic capability in sectors critical to Korean economic future.

Semiconductor investments target companies developing chip design, manufacturing equipment, and materials. KDB Venture sees semiconductor capability as Korean national priority given global supply chain importance.

Biotechnology investments focus on novel therapeutics, medical devices, and healthcare technology. Korean pharma and biotech evolution creates investment opportunity in companies addressing unmet medical needs.

Advanced materials and industrial technology investments address Korean manufacturing competitiveness. Companies developing novel materials or production technologies align with strategic sector development goals.

The firm's investment approach balances commercial viability with strategic importance. KDB Venture evaluates both financial returns and national technology development contribution.

Patient capital supports extended development timelines typical of deep tech. The KDB affiliation provides stability that allows investment in long-duration technology development.

KDB Venture has maintained active deployment in Korean deep tech throughout 2024-2025. The firm's policy bank affiliation provides capital stability independent of venture market cycles.

Semiconductor investments have increased as Korean government and industry prioritize chip independence. KDB Venture sees significant opportunity in domestic semiconductor capability development.

Biotech investments continue reflecting Korean pharmaceutical industry evolution. Novel drug development and medical device innovation attract KDB Venture attention as healthcare needs expand.

The firm's investment committee includes KDB technical staff providing diligence support in specialized sectors. This internal expertise enables better evaluation of complex technology opportunities.

Follow-on investment supports portfolio companies through development milestones. KDB Venture demonstrates patience for deep tech development that challenges pure financial investors.

KDB Venture's portfolio spans Korean technology companies across deep tech verticals. The portfolio reflects national strategic priority sectors where domestic development has commercial and strategic value.

Semiconductor portfolio companies address design, equipment, and materials subsectors. These companies contribute to Korean semiconductor ecosystem independence from foreign technology.

Biotechnology holdings include novel therapeutics and medical device companies. Korean healthcare innovation creates opportunity in companies addressing significant unmet medical needs.

Portfolio companies benefit from KDB network access to Korean industrial conglomerates and research institutions. These relationships provide commercial partnerships and exit opportunities.

KDB Venture evaluates opportunities based on both commercial viability and strategic importance. The firm looks for technology with genuine differentiation that advances Korean capability in critical sectors.

Technical differentiation is essential—companies with meaningful intellectual property and competitive barriers receive priority. Incremental improvements in established fields don't align with strategic investment thesis.

Team quality includes technical depth and commercial execution capability. KDB Venture prefers founders with relevant domain expertise and ability to build organizations as companies mature.

Korean market position and global competitiveness matter. The firm evaluates whether companies can succeed domestically before expanding internationally.

National priority alignment influences investment decisions. Companies contributing to Korean technology independence in strategic sectors receive consideration advantage.

Korean technology ecosystem connections provide effective introductions. KDB Venture maintains relationships with Korean universities, research institutions, and technology incubators.

Government program alignment creates favorable reception. Companies receiving Korean government research grants or participating in national technology programs attract KDB Venture interest.

Korean language engagement is essential for domestic opportunities. KDB Venture evaluates domestic market opportunities with expectation of local market understanding and fluency.

Strategic rationale should articulate national technology development contribution alongside commercial opportunity. The firm balances financial and strategic considerations in investment decisions.

Deep tech companies require sophisticated financial modeling accounting for extended development timelines. Standard venture metrics fail to capture deep tech investment dynamics.

Korean government funding integration affects financial projections. Companies combining KDB Venture investment with government grants require integrated financial planning.

Exit pathway modeling differs for strategic versus purely financial investors. KDB Venture exit analysis should incorporate Korean conglomerate acquisition alongside IPO paths.

Professional financial infrastructure helps Korean deep tech founders present investor materials matching institutional expectations while accurately representing technology development risk.

Preparing for Korean deep tech fundraising requires financial models that capture strategic and commercial dimensions. Our team helps Korean technology founders prepare materials that demonstrate technical differentiation and commercial potential to policy bank-aligned investors like KDB Venture.

Exploring other venture capital firms? Our comprehensive collection of VC firm reviews covers hundreds of investors across all stages and sectors.

Each review provides detailed information about investment criteria, portfolio companies, and tips for securing funding. Whether you're looking for seed-stage investors or growth equity firms, you'll find valuable insights in our VC firm guides.

Finding the right investor for your startup is crucial to your success. Take the time to research potential investors and understand their investment thesis before reaching out.

Our guides cover major venture capital firms as well as emerging managers that may be a better fit for your company's specific needs and stage.